Journal of Clinical Oncology Issues Research Articles in Sept. 1, 2022 Edition
August 30, 2022
August 30, 2022
ALEXANDRIA, Virginia, Aug. 30 -- The Journal of Clinical Oncology, a journal from the American Society of Clinical Oncology that says it disseminates clinical oncology research, published research articles on the following topics in its Sept. 1, 2022 edition:
RAPID COMMUNICATION:
* Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type . . .
RAPID COMMUNICATION:
* Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type . . .